Wolfe Research Assumes Edwards Lifesciences (EW) at Outperform

Wolfe Research analyst Mike Polark assumes coverage on Edwards Lifesciences (NYSE: EW) with a Outperform rating and a price target of $134.00.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $120.28 yesterday.

You May Also Be Interested In

• UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
• UBS Starts Amcor Plc. (AMCR) at Buy
• Piper Sandler Starts LightPath Technologies (LPTH) at Overweight